TY  - JOUR

T1  - Frailty assessment in patients with advanced/metastatic renal cell carcinoma using routine data collected during treatment with tyrosine kinase inhibitors in the STAR trial.

JO  - Journal of Clinical Oncology

UR  - https://doi.org/10.1200/jco.2025.43.16_suppl.4531

PY  - 2025/06/01

AU  - Trotter S

AU  - Royle K-L

AU  - Handforth C

AU  - Wyld L

AU  - Brown J

ED  - 

DO  - DOI: 10.1200/jco.2025.43.16_suppl.4531

PB  - American Society of Clinical Oncology (ASCO)

VL  - 43

IS  - 16_suppl

SP  - 4531

EP  - 4531

Y2  - 2025/06/08

ER  -